Methods and compounds to modulate inherited genetic diseases.
CL202601798A1Pending Publication Date: 2026-08-14DESIGN THERAPEUTICS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CL202601798
- Authority / Receiving Office
- CL · CL
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-12-05
- Filing Date
- 2026-06-01
- Publication Date
- 2026-08-14
Abstract
This disclosure relates to transcription modulator compounds, compositions, and methods for the treatment of DM1 (myotonic dystrophy type 1) and FECD (Fuchs corneal endothelial dystrophy).
Need to check novelty before this filing date? Find Prior Art